Why the study?
Viral myocarditis is prevalent in patients with COVID-19, presenting heterogeneously from clinically silent disease to life-threatening arrhythmias with hemodynamic compromise.
Population
A previously healthy 52-year-old male with suspected myocarditis and new-onset DCM after SARS-CoV-2 infection
Design
Case report
Authors
Loading...
Highlights potential cardiac complications in COVID-19; leaves open incidence, mechanisms, and management in larger cohorts.
This case highlights that COVID-19 can cause clinically silent but severe viral myocarditis leading to new-onset dilated cardiomyopathy and profound systolic dysfunction.
Oleszak et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: